相关实验视频

Updated: Jun 17, 2026

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

Published on: June 15, 2011

在患有高氏病的患者中发现新突变

Monia Anania¹, Miriam Giacomarra¹, Annalisa D'Errico¹

¹Institute for Biomedical Research and Innovation (IRIB), National Research Council (CNR), 90146 Palermo, Italy.

International journal of molecular sciences

|May 7, 2025

概括

在Gaucher病患者中发现了GBA1基因的六种新突变. 这些突变导致葡萄糖大脑酶活性降低,导致基质积累和疾病症状,有助于准确诊断.

科学领域:

遗传学遗传学是一个
生物化学生物化学
分子生物学分子生物学

背景情况:

氏病是一种自体逆向性疾病,由葡萄糖脑化酶缺乏引起.
这种缺陷主要是由GBA1基因的突变引起的,导致葡萄糖胺在溶酶体中的积累.
葡萄糖胺的积累导致了高氏病的特征症状.

研究的目的:

为了识别和描述与高氏病相关的GBA1基因中的新突变.
为了研究这些新突变对葡萄糖大脑酶活性和基质积累的影响.
为改善高氏病的诊断提供分子见解.

主要方法:

基因测序用于识别GBA1基因中的突变.
对突变类型的分析,包括过早停止密码子和误解突变.
酶活性测定用于评估葡萄糖大脑糖酶的功能.
与患者症状的临床相关性,包括肝缩和骨/血液学参与.

主要成果:

发现了六种新的GBA1突变:三种导致过早停止的编码子 (c.1578_1581dup,c.1308dup,Y492X) 和三种错误的突变 (C342F,M280L,Q247R).
这些突变导致缺失或减少葡萄糖大脑酶活性,导致病态基质积累.
在1500多名健康对照人群中,没有发现的突变.
患有这些突变的患者表现出与I型高氏病一致的临床表现.

结论:

新发现的GBA1突变通过损害葡萄糖大脑酶活性,有助于高氏病的发病.
这些发现扩大了对GBA1基因及其在高氏病中的作用的分子理解.
这些突变的表征为在受影响个体中准确的分子诊断高氏病提供了有价值的支持.

关键词:

在 GBA1 中,GBA1 是 GBA1 的代码.戈舍氏病是戈舍氏病的一种疾病.葡萄糖大脑化酶的使用新型突变新型突变

更多相关视频

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease

Published on: December 20, 2017

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues

Published on: August 23, 2024

相关概念视频

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

Huntington Disease l: Introduction

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...